JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹28 Cr | ₹8.12 Cr | ₹17 Cr | ₹9.27 Cr | ₹19 Cr |
What is the latest Cash Flow from Operating Activities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹8.12 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹9.27 Cr |
| Mar2021 | ₹19 Cr |
How is Cash Flow from Operating Activities of JENBURKT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | 243.50 | |
| Mar2024 | ₹8.12 Cr | -52.36 | |
| Mar2023 | ₹17 Cr | 83.93 | |
| Mar2022 | ₹9.27 Cr | -52.35 | |
| Mar2021 | ₹19 Cr | - | |
Compare Cash Flow from Operating Activities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹453.2 Cr | 4.1% | 5.4% | -1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 4.1% |
5.4% |
-1.5% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses